Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $11.0 million.

  • Medifast's Shares Outstanding (Weighted Average) rose 46.66% to $11.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $11.0 million, marking a year-over-year increase of 46.66%. This contributed to the annual value of $11.0 million for FY2025, which is 46.66% up from last year.
  • As of Q4 2025, Medifast's Shares Outstanding (Weighted Average) stood at $11.0 million, which was up 46.66% from $11.0 million recorded in Q3 2025.
  • In the past 5 years, Medifast's Shares Outstanding (Weighted Average) registered a high of $11.8 million during Q1 2021, and its lowest value of $10.9 million during Q1 2023.
  • Over the past 5 years, Medifast's median Shares Outstanding (Weighted Average) value was $11.0 million (recorded in 2025), while the average stood at $11.2 million.
  • Per our database at Business Quant, Medifast's Shares Outstanding (Weighted Average) tumbled by 599.64% in 2023 and then soared by 49.37% in 2025.
  • Medifast's Shares Outstanding (Weighted Average) (Quarter) stood at $11.7 million in 2021, then fell by 4.36% to $11.2 million in 2022, then decreased by 2.78% to $10.9 million in 2023, then rose by 0.42% to $10.9 million in 2024, then rose by 0.47% to $11.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $11.0 million for Q4 2025, versus $11.0 million for Q3 2025 and $11.0 million for Q2 2025.